Evidence map›Paper›PMID 26892908›Full record

ReviewCurrent diabetes reports2016

The Affordable Care Act and Diabetes Diagnosis and Care: Exploring the Potential Impacts.

Rebecca Myerson, Neda Laiteerapong

Abstract readReview
In one paragraph

Review in Current diabetes reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Determinants of Diabetes Disease Management, 2011-2019.Healthcare (Basel, Switzerland) · 2021
    Article
  10. Review
  11. Article
  12. Reply to Q. Chu et al.JCO global oncology · 2021
    Article
  13. Article
  14. Article
  15. Observational
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Rebecca MyersonHarris School of Public Policy, University of Chicago, 1155 E. 60th St, Chicago, IL, 60637, USA. rmyerson1@uchicago.edu.
Neda LaiteerapongDepartment of Medicine, University of Chicago, 5847 S Maryland Ave, MC 2007, Chicago, IL, 60637, USA. nlaiteer@medicine.bsd.uchicago.edu.

Funding

Research Design, Data, and Analytics CoreP30DK092949 · NIDDK · UNIVERSITY OF CHICAGO · PI MARSHALL H CHIN · 2011 to 2026
$10.0M
The University of Chicago and Northwestern University Predoctoral Health Services Research Program-RenewalT32HS000084 · AHRQ · UNIVERSITY OF CHICAGO · PI KONETZKA, RITA TAMARA, MELTZER, DAVID O · 1998 to 2024
$7.6M
Linking the Legacy Effect in Type 2 Diabetes to Clinical Decision MakingK23DK097283 · NIDDK · UNIVERSITY OF CHICAGO · PI LAITEERAPONG, NEDA · 2012 to 2016
$880k
The Impact of State-Varying Components of the Affordable Care Act on Prescription Fills for Diabetes and HypertensionR36HS023964 · AHRQ · UNIVERSITY OF CHICAGO · PI MYERSON, REBECCA · 2015 to 2015
$22k
AHRQ HHS R36 HS023964AHRQ HHS T32 HS000084NIDDK NIH HHS K23 DK097283NIDDK NIH HHS P30 DK092949
6 · The paper itself

Abstract

This article reviews available data on the implications of the Affordable Care Act (ACA) for the diagnosis and care of type 2 diabetes. We provide a general overview of the major issues for diabetes diagnosis and care, and describe the policies in the ACA that affect diabetes diagnosis and care. We also estimate that approximately 2.3 million of the 4.6 million people in the USA with undiagnosed diabetes aged 18-64 in 2009-2010 may have gained access to free preventive care under the ACA, which could increase diabetes detection. In addition, we note two factors that may limit the success of the ACA for improving access to diabetes care. First, many states with the highest diabetes prevalence have not expanded Medicaid eligibility, and second, primary care providers may not adequately meet the increase in Medicaid patients because federal funding to increase provider reimbursement for Medicaid visits recently expired. We close by discussing current gaps in the literature and future directions for research on the ACA's impact on diabetes diagnosis, care, and health outcomes.

Indexed as

Patient Protection and Affordable Care ActDiabetes MellitusHealth PolicyHumansMedicaidUnited StatesCareDiabetesDiagnosisHealth care reformHealth policyPopulation health

Identifiers

PMID26892908
PMCPMC4807352

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.